//
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
Circadian-Regulated Cell Death in Cardiovascular Diseases